| User's Publication |
|
12014
Somchai P, Phongkitkarun K, Kueanjinda P, Jamnongsong S, Vaeteewoottacharn K, Luvira V, Okada S, Jirawatnotai S, Sampattavanich S.
Novel Analytical Platform For Robust Identification of Cell Migration Inhibitors.
Sci Rep
2020
PubMed ID: 31969633
|
|
13336
Pan YR, Wu CE, Yeh CN.
ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner.
Biomolecules
2020
PubMed ID: 33182492
|
|
13539
Nagaoka K, Ogawa K, Ji C, Cao KY, Bai X, Mulla J, Cheng Z, Wands JR, Huang CK.
Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis
Dig Dis Sci
2020
May 22
PubMed ID: 32445050
|
|
12588
Yoh T, Hatano E, Kasai Y, Fuji H, Nishi K, Toriguchi K, Sueoka H, Ohno M, Seo S, Iwaisako K, Taura K, Yamaguchi R, Kurokawa M, Fujimoto J, Kimura T, Uemoto S, Nishi E.
Serum Nardilysin, a Surrogate Marker for Epithelial-Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection
Clin Cancer Res
2019
25(2):619-628
PubMed ID: 30352908
|
|
12589
Miyata T, Yamashita YI, Yoshizumi T, Shiraishi M, Ohta M, Eguchi S, Aishima S, Fujioka H, Baba H.
CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis
Cancer Sci
2019
110(10):3197-3203
PubMed ID: 31361379
|
|
11220
You HL, Liu TT, Weng SW, Chen CH, Wei YC, Eng HL, Huang WT.
Association of IRS2 overexpression with disease progression in intrahepatic cholangiocarcinoma.
Oncol Lett
2018
PubMed ID: 30250623
|
|
4347
Lin HY, Tey SL, Ho Y, Chin YT, Wang K, Whang-Peng J, Shih YJ, Chen YR, Yang YN, Chen YC, Liu YC, Tang HY, Yang YS.
Heteronemin Induces Anti-Proliferation in Cholangiocarcinoma Cells via Inhibiting TGF-β Pathway.
Mar Drugs
2018
PubMed ID: 30563284
|
|
10290
Quintavalle C, Burmeister K, Piscuoglio S, Quagliata L, Karamitopoulou E, Sepe R, Fusco A, Terracciano LM, Andersen JB, Pallante P, Matter MS.
High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy.
Mol. Carcinog.
2017
56:2146-2157
PubMed ID: 28467612
|
|
10333
Huang G-, Liu TT, Weng SW, You HL, Wei YC, Chen CH, Eng HL, Huang WT.
CUL4A overexpression as an independent adverse prognosticator in intrahepatic cholangiocarcinoma.
BMC Cancer
2017
17:395
PubMed ID: 28576144
|
|
9871
Hoshino H, Ohta M, Ito M, Uchimura K, Sakai Y, Uehara T, Low S, Fukushima M, Kobayashi M.
Apical membrane expression of distinct sulfated glycans represents a novel marker of cholangiolocellular carcinoma.
Lab. Invest.
2016
96:1246-1255
PubMed ID: 27748735
|
|
3735
Saha SK et al
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma.
Cancer Discov
2016
6(7):727-39
PubMed ID: 27231123
|
|
5025
Sakamoto K, Imai K, Higashi T, Taki K, Nakagawa S, Okabe H, Nitta H, Hayashi H, Chikamoto A, Ishiko T, Beppu T, Baba H.
Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer.
Cancer Sci
2015
106(9):1153-62
PubMed ID: 26132727
|
|
9170
Sheng-Huei Yang 1, Hung-Yun Lin, Vincent H S Chang, Chien-Chung Chen, Yun-Ru Liu, Jinghan Wang, Keqiang Zhang, Xiaoqing Jiang, Yun Yen
Lovastatin Overcomes Gefitinib Resistance Through TNF-α Signaling in Human Cholangiocarcinomas With Different LKB1 Statuses in Vitro and in Vivo
Oncotarget
2015
6 (27), 23857-73
PubMed ID: 26160843
|
|
12541
Soejima Y, Inoue M, Takahashi Y, Uozaki H, Sawabe M, Fukusato T.
ntegrins αvβ6, α6β4 and α3β1 are down-regulated in cholangiolocellular carcinoma but not cholangiocarcinoma
Hepatol Res
2014
44(14):E320-34
PubMed ID: 24552196
|
|
12544
Kumagai A, Fukushima J, Takikawa H, Fukuda T, Fukusato T.
Enhanced expression of farnesoid X receptor in human hepatocellular carcinoma
Hepatol Res
2013
43(9):959-69
PubMed ID: 23369163
|
|
8365
Ishii T, Yasuchika K, Suemori H, Nakatsuji N, Ikai I, Uemoto S.
Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma.
Cancer Lett.
2010
294:25-34
PubMed ID: 20149523
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
|
|
3575
Komori J, Marusawa H, Machimoto T, Endo Y, Kinoshita K, Kou T, Haga H, Ikai I, Uemoto S, Chiba T.
Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma.
Hepatology
2008
47(3):888-96
PubMed ID: 18306229
|
|
3335
Yoshino K, Iimura E, Saijo K, Iwase S, Fukami K, Ohno T, Obata Y, Nakamura Y.
Essential role for gene profiling analysis in the authentication of human cell lines.
Hum Cell
2006
19(1):43-8
PubMed ID: 16643607
|
|
3077
Nakatsu N, Yoshida Y, Yamazaki K, Nakamura T, Dan S, Fukui Y, Yamori T
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
Mol Cancer Ther
2005
4:399-412
PubMed ID: 15767549
|
|
3334
Obama, Kazutaka, Ura, Katsuaki, Satoh, Seiji, Nakamura, Yusuke, Furukawa, Yoichi
Up-regulation of PSF2, a member of the GINS multiprotein complex, in intrahepatic cholangiocarcinoma
Oncol Res
2005
14:701-706
PubMed ID: 16077978
|
|
3346
Yokoo, Hideki, Kondo, Tadashi, Fujii, Kazuyasu, Yamada, Tesshi, Todo, Satoru, Hirohashi, Setsuo
Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells.
Hepatology
2004
40:609-17
PubMed ID: 15349899
|
|
3703
Sanada T, Yokoi S, Arii S, Yasui K, Imoto I, Inazawa J.
Skp2 overexpression is a p27Kip1-independent predictor of poor prognosis in patients with biliary tract cancers.
Cancer Sci
2004
95(12):969-76
PubMed ID: 15596046
|
Back
Top
CELL BANK Website
